Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Rising Number of Cancer Cases Making India Potential Market for Anti-Cancer Drugs, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Oncology Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 21, 2012 - Netscribes, Inc.
Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement
ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012 - ALPCO
Foamix’s Minocycline Foam – 100% Effective in Impetigo Phase II Clinical Trial with No Side Effects. 80% Improved Significantly After 3 Days of Treatment.
Targets a $1 billion a year market. Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). - March 20, 2012 - Foamix Ltd
Paragon Innovations Helps Diabetics Cut the (Refrigerator) Cord, with Design of New Temperature Control Device
Say goodbye to coolers and ice packs. Available this summer from Kewl Innovations, amazing nano-technology-driven device will keep medicine temps consistent – for days. - March 19, 2012 - Paragon Innovations, Inc.
"Ophthalmic Drugs Market Will Reach $18.7 Billion in 2012" Visiongain Report Predicts
A new report by visiongain predicts that the world market for ophthalmic drugs will reach $18.7 billion for 2012. That revenue forecast appears in Ophthalmic Drugs: World Market Prospects 2012-2022, published in March 2012. Visiongain is a business information provider based in London, UK. - March 18, 2012 - visiongain
High Infectious Diseases Incidence Drives the Indian Anti-Infective Pharmaceutical Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Anti-Infective Pharmaceuticals Market in India 2011, as part of Netscribes’ Healthcare Industry report series. - March 17, 2012 - Netscribes, Inc.
Indian Anti-Diabetic Pharma Market is Largely Driven by Huge Diabetic Patient Base, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Anti-Diabetic Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 17, 2012 - Netscribes, Inc.
New Book Release
CGMP University inc of San Jose announced the release of two books: 1. How to design a Pharmaceutical Quality system. 2. Principles of design controls for medical device. - March 16, 2012 - cGMP UNIVERSITY INC.
Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Gobburu will present “Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions” March 20, 2012. - March 16, 2012 - Rosa & Co LLC
Foamix Granted Comprehensive US Patent for PerFoam® – Ideal Foam Treatment for Head Lice and Scabies
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 15, 2012 - Foamix Ltd
The 2012 BioProcess International Awards - Honoring a Decade of BioProcess
Awarding 4 Awards in pillar of bioprocess: Upstream, downstream and manufacturing. Awards include Technology of the Decade, Technical Application of the Decade, Collaboration of the Decade, and Thought Leader of the Decade - March 14, 2012 - BioProcess International
Rising Tendencies Towards Self-Treatment Drives the Indian OTC Drug Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the OTC Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 14, 2012 - Netscribes, Inc.
Foamix Obtains US Patent for Iodine Foam – Innovative Treatment for Heat Burns and Warfare Materials, as Well as Fungal and Bacterial Infection
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd
New Foamix US Patent: "Foamable Compositions, Kits and Methods for Hyperhidrosis" - First in Class Foam for Excessive Sweating
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd
Data Migrations Spike; Sentrx Assists Customers in Addressing New Guidance Concerning the Development Safety Update Report (DSUR)
Sentrx, an industry leader in providing outsourced drug safety solutions, comprehensive pharmacovigilance solutions and data management services, weighs in on new DSUR guidance. - March 10, 2012 - Sentrx
Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012
PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway. - March 10, 2012 - Rosa & Co LLC
The Growing Pharmaceutical Sector Drives the Indian Pharmacy Retail Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches its Pharmacy Retail Market in India Report 2012 covering one of the very potential markets in India having strong growth prospects in future. It is a part of Netscribes’ Healthcare Series reports. - March 09, 2012 - Netscribes, Inc.
Cypin Production’s Branded Generics Conference Attracts Unexpected Breadth of Attendees
Some truly ground-breaking topics and dynamic speakers brought attendees from all over the world to the first Branded Generics TM conference held recently in Philadelphia. - March 09, 2012 - CYPIN PRODUCTION LLC
The New AdvantaTube(TM) Sealer & Sterile Welder Available Now from AdvantaPure(R); Manufactured to Seal & Weld AdvantaFlex(R) Biopharmaceutical Grade Tubing
Specially developed for the biopharmaceutical industry, the AdvantaTube Sterile Welder and the AdvantaTube Sealer are now offered by AdvantaPure. The units are programmed to weld and seal the company’s AdvantaFlex biopharmaceutical grade TPE tubing and were added to the product line due to customer requests. The ability to seal and weld tubing in a biopharmaceutical process is an important function, and not all tubing materials possess the capability to be welded and sealed. - March 07, 2012 - NewAge Industries, Inc.
IonSense Introduces the DART®-OS Source. Expands Its OpenSpot Mass Spectrometry™ Product Line
OpenSpot® Sample Cards Facilitate Simpler Analysis, Eliminating Most Consumables and Solvents, Reducing Lab Waste. Exhibited at Pittcon 2012. Booth #2609. - March 06, 2012 - IonSense, Inc.
Ameridose Continues Outstanding Sustainability Performance
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to present outstanding 2011 sustainability results. Recycled materials generated from Ameridose facilities totaled 1.9 million lbs. Corrugated cardboard dominated with over 600,000 lbs, empty glass... - March 06, 2012 - Ameridose, LLC
Sentrx Introduces Patient Safety Nation – The No. 1 Pool of Patient Safety Focused Professionals on the Planet
Sentrx, an industry leader in providing outsourced drug safety solutions and comprehensive pharmacovigilance solutions, introduces the Patient Safety Nation. - March 04, 2012 - Sentrx
DAVA Oncology, LP- Alexander E. Denes, M.D., F.A.C.P. Joins DAVA Oncology as Medical Director
DAVA Oncology, LP is pleased to announce the addition of Alex Denes, MD as a member of the medical oncology support staff. Dr. Denes is from Washington University School of Medicine, where he currently serves as Associate Professor of Medicine. Dr. Denes has an extensive background as a clinician... - March 03, 2012 - Dava Oncology, LP
"Cancer Drug Market Will Reach $75 Billion in 2012" Visiongain Report Predicts
A new report by visiongain predicts that the world market for cancer-treating drugs will reach $75 billion for 2012. That revenue forecast appears in Leading Anti-Cancer Drugs and Associated Market 2012-2022, published in February 2012. Visiongain is a business information provider based in London, UK. - March 02, 2012 - visiongain
Rosa Announces Publication of Its PhysioPD™ Model Qualification Method and Series of Educational Events
Series of Seminars and Workshops to be held in 2012 across the US and in Europe. - March 01, 2012 - Rosa & Co LLC
CPC Scientific Announces Its Peptide Facility Passes 2nd Successful FDA Inspection
CPC Scientific is pleased to announce that its 50,000 sf cGMP peptide facility has successfully passed a second US Food and Drug Administration (FDA) inspection. It involved the investigator inspecting CPC Scientific’s peptide production facilities, manufacturing processes, laboratory control... - February 27, 2012 - CPC Scientific
Parameter Expands Stability Storage with -20 Degree Celsius Units
Unique design maintains ICH uniformity even during defrost cycles. - February 24, 2012 - Parameter Generation and Control
Founder of Evential Cheryl Clarke Gives Your Pharma Launch the Creative Edge in February’s Edition of Healthcare Global
With increasing restrictions and levels of healthcare compliance which have to be met when marketing products to the pharmaceutical industry, organisations are left to come up with more inventive, creative and engaging events if they want to promote new innovations to the market. - February 23, 2012 - WDM Group
GiiConference.com: Drug Discovery Chemistry 2012 in San Diego
Register for the Drug Discovery Chemistry 2012 conferences taking place April 17-19, 2012. - February 23, 2012 - Global Information Inc.
Molecular Connections of India Develops “Ureome Database” with NCI’s Radiation Oncology Branch
Molecular Connections today announced a new collaborative Partnership to develop a “Ureome Database” with the NIH National Cancer Institute. In doing so scientists hope that, access to clinically applicable information will aid in the early detection of various cancers as well as elucidate novel signaling pathways. - February 22, 2012 - Molecular Connections Pvt. Ltd.
Biomedica Immunoassays Appoints ALPCO Diagnostics as Its Exclusive Distributor in Canada
ALPCO Diagnostics was recently appointed as Biomedica Immunoassays' exclusive distributor in Canada. - February 15, 2012 - ALPCO
Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing
Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
Foamix Obtains India Patent for Its Emollient Foam Platform – The Ideal Vehicle for Dermatological Drugs
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a patent from Indian Patent Office # IN 249626, entitled “Foam Carrier Containing Amphiphilic Copolymeric Gelling Agent.” - February 10, 2012 - Foamix Ltd
Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development
Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity. - February 07, 2012 - Rosa & Co LLC
Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Derendorf, will present “PK/PD-based Development of Anti-infective Agents” February 13, 2012. - February 06, 2012 - Rosa & Co LLC
GiiResearch.com: Nanotech-Enabled Drug Delivery Therapeutics Set to Grow to $136 Billion by 2021
Nanotech-enabled drug delivery therapeutics is set to grow from a current value of $2.3 billion to $136 billion by the year 2021. - February 05, 2012 - Global Information Inc.
Rosa to Present at 2012 Keystone Symposia: Cancer and Metabolism
Modeling analysis enables understanding efficacy of large numbers of potential drug combinations. - February 03, 2012 - Rosa & Co LLC
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
Industry Presenters Will Focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development - January 30, 2012 - Rosa & Co LLC
Pfizer and Rosa to Present at 2012 Keystone Symposia: Pathogenesis of Diabetes
Insulin degradation and the mechanisms controlling it have significant impact on glucose homeostasis and diabetes. - January 26, 2012 - Rosa & Co LLC
Clinical Financial Services (CFS) Expands Internationally with Office in Edinburgh, Scotland
Clinical Financial Services, LLC (CFS), a specialty service provider focused on the business and financial management activities for clinical trials, has expanded its global presence by opening a new office in Edinburgh, Scotland. April Mulroney, CA, CPA, having most recently served as Vice... - January 26, 2012 - Clinical Financial Services
Virtual Job Summit for Postgraduate Life Scientists Opens February 1st
Bio Careers hosts it's second Virtual Job Summit for postgraduate scientists starting February 1st. The Summit is free for all Bio Careers Members, which comprise graduates and postdocs from the top 25% of graduate programs worldwide. - January 25, 2012 - Bio Careers
Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conference 2012
Integration of PK/PD and mechanistic physiological models improves drug development in infants. - January 24, 2012 - Rosa & Co LLC
GiiResearch.com: Antifungals Market to Reach $10.8 Billion by 2017
The global Antifungals Market will grow at a moderate rate due to the impact of generic erosion in the dermatophytosis and candidiasis markets. - January 21, 2012 - Global Information Inc.
GiiResearch.com: Global Musculoskeletal Disorders Therapeutics Market to Witnesses Moderate Growth as Generic Share Continues to Rise
Global Musculoskeletal Disorders market was approximately valued $33.4 billion, representing a compound annual growth rate (CAGR) of 5.7% between 2002 and 2010. - January 21, 2012 - Global Information Inc.
BioRegenerative Sciences, Inc. Signs Memorandum of Understanding with Nurture Earth Pvt. Ltd. to Form Stem Cell Joint Venture in India
BioRegenerative Sciences, Inc. of San Diego, CA signs MOU with Nurture Earth, Pvt., Ltd. of India to form joint venture called BioRegenerative Sciences India (BRS India). The new joint venture, BRS India will produce, test, register, and market and sell BRS' stem cell-based therapeutic products in the Asian markets. - January 20, 2012 - BioRegenerative Sciences, Inc.
MResult Corporation to Sponsor 9th Annual Pharmaceutical Compliance Congress
MResult Corporation is proud to announce its sponsorship of the upcoming 9th Annual Pharmaceutical Compliance Congress hosted by CBI in Washington, D.C. At the event, MResult representatives will be showcasing the firm’s Aggregate Spend Solution application. This customized compliance... - January 11, 2012 - MResult Corporation
Medimix Europe Moves to New Offices in Aldersgate, London
Medimix Europe will see many changes in 2012: new staff members, new offices and new energy. It is poised to utilize latest advances in online technologies and social media to meet challenges in changing markets for the healthcare industries. - December 31, 2011 - Medimix International
AdvaCare Looking for Qualified Importers & Distributors in Key Markets
As AdvaCare is expanding into new markets, as well as growing its product range to meet demand in these new markets, AdvaCare is interested in suitable importers and distributors joining the AdvaCare team. AdvaCare is interested in qualified distributors, preferably with product registration... - December 29, 2011 - AdvaCare Pharmaceutical
AdvaCare Expanding Into East European Market
AdvaCare, already having a strong presence in countries throughout Africa, Asia, the Middle East and South America, is now introducing its Pharmaceutical, Antimalarial, Oncology, Veterinary and Medical Supplies products to the East European region. AdvaCare is an American company with production in... - December 28, 2011 - AdvaCare Pharmaceutical
Declan Doogan of Amarin to Keynote CHI’s Conference on Phase III Clinical Trials
Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum. - December 26, 2011 - Cambridge Healthtech Institute